Status:
COMPLETED
Predicting Disease Progression and/or Recurrence in Cancer
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Patient Reported Outcome Measures
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective study addressing the challenge of predicting disease progression and/or recurrence in patients diagnosed with metastatic colorectal, pancreatobiliary, or esophagogastric cancer t...
Detailed Description
This research study is evaluating how patient-reported outcomes (e.g. symptoms, quality of life) and biomarkers compare to standard of care clinical assessments such as imaging and tumor markers in pr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients must have histologically confirmed colorectal, pancreatobiliary, or esophagogastric cancer.
- Diagnosed with metastatic disease
- Age \> 18 years.
- Patients must be starting new line of anti-cancer therapy.
- Patient must be English-speaking.
- Exclusion Criteria
- Unwilling or unable to participate in the study
- Non-metastatic disease
- Not starting new anti-cancer treatment
- Cognitive issues interfering with ability to participate.
- Active, unstable, untreated serious mental illness interfering with ability to participate.
- Patient does not speak English.
Exclusion
Key Trial Info
Start Date :
May 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 19 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04776837
Start Date
May 15 2019
End Date
November 19 2021
Last Update
August 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02115